Iranian medicine has been saving the lives of Americans while the illegal US-led sanctions against the Islamic Republic have been adversely affecting the lives of many Iranian patients.
A Sunday report on the website of the Wall Street Journal said the US Defense Department needs Iranian-researched and -produced medicine to treat the foreign forces in Afghanistan who get bitten by “Oxus cobras, Haly’s pit vipers” and other snakes peculiar to southwest Asia.
“Medical guidance issued by US Central Command says drugs made by Iran’s Razi Vaccine & Serum Research Institute ‘should be the first line of antivenin therapy,’” the report cited a US officer as saying.
“The Iranian antivenin is the best,” said Colonel Rob Russell, the medical director of the pharmacy at British-run Camp Bastion hospital, adjacent to the Camp Leatherneck US Marine base in southern Afghanistan.
The report highlighted the fact that the antivenins produced in the US and approved by the US Food and Drug Administration (FDA) “won’t work on Afghan snake bites.”
This comes as the US-engineered sanctions are putting the lives of Iranian patients in jeopardy.
Though the US has not imposed any bans on American firms to sell medicine and medical supplies to Iran, exporters have been required to apply for special licenses. In the wake of the sanctions, the impossibility of transferring money through banks has cast its cumbersome shadow upon medicine and healthcare in Iran, thereby jeopardizing the lives of millions of patients suffering from special diseases such as thalassemia, hemophilia, hepatitis, multiple sclerosis, diabetes, and many others.
Read More: Here
